BioCentury | Apr 5, 2019
Company News

Management tracks: Zealand taps Alnylam’s Dulac as CEO, plus ICER, Jnana and more

...director, will become interim chairman. Diggle is founder and CEO of U.K. life sciences investor Vulpes Investment Management...
BioCentury | Oct 10, 2016
Financial News

Oxford BioMedica completes private placement

...L6 million ($7.7 million) Shares: 199.1 million Price: 3p Shares after offering: 3.1 billion Investor: Vulpes Investment Management...
BioCentury | Sep 19, 2016
Financial News

Oxford BioMedica proposes private placement

...Private placement To be raised: L6 million ($7.9 million) Shares: 199.1 million Price: 3p Investor: Vulpes Investment Management WIR...
BioCentury | Jun 29, 2015
Financial News

Proteome Sciences completes placing

...L2.5 million ($4 million) Shares: 13.9 million Price: 18p Shares after offering: 229.4 million Investors: Vulpes Investment Management...
Items per page:
1 - 4 of 4
BioCentury | Apr 5, 2019
Company News

Management tracks: Zealand taps Alnylam’s Dulac as CEO, plus ICER, Jnana and more

...director, will become interim chairman. Diggle is founder and CEO of U.K. life sciences investor Vulpes Investment Management...
BioCentury | Oct 10, 2016
Financial News

Oxford BioMedica completes private placement

...L6 million ($7.7 million) Shares: 199.1 million Price: 3p Shares after offering: 3.1 billion Investor: Vulpes Investment Management...
BioCentury | Sep 19, 2016
Financial News

Oxford BioMedica proposes private placement

...Private placement To be raised: L6 million ($7.9 million) Shares: 199.1 million Price: 3p Investor: Vulpes Investment Management WIR...
BioCentury | Jun 29, 2015
Financial News

Proteome Sciences completes placing

...L2.5 million ($4 million) Shares: 13.9 million Price: 18p Shares after offering: 229.4 million Investors: Vulpes Investment Management...
Items per page:
1 - 4 of 4